Chau I - Search Results

1

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.

Khan K, Cunningham D, Peckitt C, Barton S, Tait D, Hawkins M, Watkins D, Starling N, Rao S, Begum R, Thomas J, Oates J, Guzzardo V, Fassan M, Braconi C, Chau I. Khan K, et al. Among authors: chau i. Oncotarget. 2016 Mar 15;7(11):12672-81. doi: 10.18632/oncotarget.7208. Oncotarget. 2016. PMID: 26862857 Free PMC article. Clinical Trial.

2

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.

Chau I, Webb A, Cunningham D, Hill M, Waters JS, Norman A, Massey A. Chau I, et al. Br J Cancer. 2001 Nov 2;85(9):1258-64. doi: 10.1054/bjoc.2001.2036. Br J Cancer. 2001. PMID: 11720458 Free PMC article. Clinical Trial.

3

An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.

Chau I, Webb A, Cunningham D, Hill M, Rao S, Ageli S, Norman A, Gill K, Howard A, Catovsky D. Chau I, et al. Br J Haematol. 2001 Dec;115(4):786-92. doi: 10.1046/j.1365-2141.2001.03181.x. Br J Haematol. 2001. PMID: 11843810 Free article. Clinical Trial.

4

Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?

Chau I, Cunningham D. Chau I, et al. N Engl J Med. 2002 Apr 4;346(14):1085-7. doi: 10.1056/NEJM200204043461412. N Engl J Med. 2002. PMID: 11932478 No abstract available.

5

Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer.

Maisey N, Chau I, Cunningham D, Norman A, Seymour M, Hickish T, Iveson T, O'Brien M, Tebbutt N, Harrington A, Hill M. Maisey N, et al. Among authors: chau i. J Clin Oncol. 2002 Jul 15;20(14):3130-6. doi: 10.1200/JCO.2002.09.029. J Clin Oncol. 2002. PMID: 12118027 Clinical Trial.

6

Chemotherapy in colorectal cancer: new options and new challenges.

Chau I, Cunningham D. Chau I, et al. Br Med Bull. 2002;64:159-80. doi: 10.1093/bmb/64.1.159. Br Med Bull. 2002. PMID: 12421732 Review.

7

Gemcitabine and its combinations in the treatment of malignant lymphoma.

Chau I, Watkins D, Cunningham D. Chau I, et al. Clin Lymphoma. 2002 Sep;3(2):97-104. doi: 10.3816/clm.2002.n.015. Clin Lymphoma. 2002. PMID: 12435288 Review.

8

Adjuvant therapy in colon cancer: current status and future directions.

Chau I, Cunningham D. Chau I, et al. Cancer Treat Rev. 2002 Oct;28(5):223-36. doi: 10.1016/s0305-7372(02)00047-6. Cancer Treat Rev. 2002. PMID: 12435370 Review.

9

Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies.

Chau I, Rigg A, Cunningham D. Chau I, et al. Crit Rev Oncol Hematol. 2003 Feb;45(2):151-76. doi: 10.1016/s1040-8428(02)00015-x. Crit Rev Oncol Hematol. 2003. PMID: 12604127 Review.

10

Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.

Chau I, Harries M, Cunningham D, Hill M, Ross PJ, Archer CD, Norman AR, Wotherspoon A, Koh DM, Gill K, Uzzell M, Prior Y, Catovsky D. Chau I, et al. Br J Haematol. 2003 Mar;120(6):970-7. doi: 10.1046/j.1365-2141.2003.04226.x. Br J Haematol. 2003. PMID: 12648066 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters